| Article Access Statistics|
| Viewed||1183 |
| Printed||20 |
| Emailed||0 |
| PDF Downloaded||133 |
| Comments ||[Add] |
Click on image for details.
| NI FEATURE: THE QUEST - ORIGINAL ARTICLE
|Year : 2019 | Volume
| Issue : 3 | Page : 787--791
Guidelines versus ground lines: Tuberculosis of the central nervous system
Satish V Khadilkar1, Nikhil D Kadam2, Rahul V Kulkarni3, Chandrashekhar M Meshram4, Archana R Meshram5, Bhagyadhan A Patel6, Akash H Chheda1
1 Department of Neurology, Bombay Hospital, Mumbai, Maharashtra, India
2 Department of Neurology, Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals, Mumbai, Maharashtra, India
3 Department of Neurology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India
4 Department of Neurology, Brain and Mind Institute, Nagpur, Maharashtra, India
5 Department of Preventive and Social Medicine, Grant Medical College, Mumbai, Maharashtra, India
6 Department of Neurology, Sterling Hospital, Ahmedabad, Gujarat, India
Aim: This questionnaire-based national survey is aimed at understanding the patterns of practice of various aspects of central nervous system (CNS) tuberculosis (TB) among neurologists.
Settings and Design: Neurology department of a tertiary medical college.
Materials and Methods: A questionnaire was sent through email to all practicing neurologists in India. The responses were analyzed.
Statistical Analysis: Inferential statistics.
Results: In all, 144 responses were received (out of the 853 questionnaires sent). The major discrepancies were in the primary antitubercular drug regimen (HRZE + HR), duration for tubercular meningitis (TBM) [12 months] and tuberculoma (12–18 months) to develop, follow-up (varied), linezolid use (varied), proportion of drug-resistant cases (<25%), and not taking histological aids (91%). The cerebrospinal fluid (CSF) TB polymerase chain reaction (PCR) utility (75%), not using CSF adenosine deaminase [ADA] (58%), the strategy to stop antitubercular drugs, and the use of steroids (77%) were according to guidelines.
Conclusion: The present survey, for the first time, provides ground-level evidence of various aspects of CNS TB as practiced by neurologists in India. The major diversity was observed in therapeutics such as the choice of antitubercular drugs, its duration, linezolid use beyond the recommended duration, and knowledge of drug resistance. The monitoring aspects of CNS TB also showed variations. The investigational aspects of CNS TB such as using TB PCR, not using CSF ADA, and regular neuroimaging revealed a good clinical practice. Other CSF parameters require uniformity. This survey thus helps to identify areas of future work in CNS TB in India.
Dr. Satish V Khadilkar
Room No. 110, First Floor, New Wing, Bombay Hospital Institute of Medical Sciences, 12, New Marine Lines, Mumbai - 400 020, Maharashtra
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*